Integrated Wealth Concepts’s Aerie Pharmaceuticals AERI Stock Holding History

Integrated Wealth Concepts’s Portfolio AERI Stock Details AERI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-11,185	Closed	-$169K	–	1088
2022 Q3	$169K	Sell	11,185 -1,509	-12%	-$17.5K	0.01%	886
2022 Q2	$95K	Buy	+12,694	New	+$89.5K	﹤0.01%	937

Integrated Wealth Concepts's AERI Position: Q4 2022 in Review

Integrated Wealth Concepts sold out of Aerie Pharmaceuticals (AERI) in Q4 2022, closing a stake of 11,185 shares — an estimated $169K sold.

Integrated Wealth Concepts first reported a position in AERI in Q2 2022 and held it in 2 quarters. The position peaked at $169K in Q3 2022. 0 funds tracked by Wall St. Rank hold AERI as of Q4 2022.

Integrated Wealth Concepts reported no remaining Aerie Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
Integrated Wealth Concepts sold 11,185 Aerie Pharmaceuticals shares in Q4 2022, an estimated $169K.
Integrated Wealth Concepts first reported a position in Aerie Pharmaceuticals in Q2 2022 and held it in 2 quarters.
Integrated Wealth Concepts's Aerie Pharmaceuticals position peaked at $169K in Q3 2022.
0 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2022.

Based on Integrated Wealth Concepts's 13F filing for Q4 2022, filed 13 Feb 2023.